Reaction

Lower Respiratory Tract Infection Bacterial reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 508 reports · 15 co-occurring drugs

As of the last recalculation, Lower Respiratory Tract Infection Bacterial appears in 508 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is DORNASE ALFA (PRR 78.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dornase Alfa3578.578.6
Lumacaftor And Ivacaftor1258.758.8
Cefuroxime1347.847.8
Piperacillin And Tazobactam1446.146.1
Gentamicin1341.841.8
Dextrose1341.541.5
Dextrose Monohydrate1340.940.9
Gentamicin Sulfate1540.140.1
Piperacillin Sodium And Tazobactam Sodium1634.534.5
Piperacillin Sodium,Tazobactam Sodium2133.833.8
Ivacaftor631.331.3
Norepinephrine727.227.2
Tobramycin1322.722.7
Amikacin922.022.0
Elexacaftor, Tezacaftor, And Ivacaftor516.616.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.